glp-1 lean mass loss Muscle and GLP-1R agonists use Balancing weight and muscle loss
Description
Together, they shorten lives, reduce quality of life, and place a growing burden on healthcare systems worldwide

Results From initially screened 1759 articles, 8 studies (557 individuals) were analysed

A : No, this study was a controlled animal trial specifically mapped in mouse models of stress, and further human clinical trials are required
Nyborg, N

J Endocrine Soc
The top 10 predictors for each cancer highlighted critical clinical factors that may modify the impact of GLP-1RAs on cancer risk (eFigure 5AD in Supplement 1)
